CYNTHIA JENSEN: Open Payments
NPI 1902835473 · PASCAGOULA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 38 payments from 14 companies in 2025. Trend: 2023 $501 · 2024 $666 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $201 |
| ABIOMED | 2 | $71 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $47 |
| Philips North America LLC | 1 | $47 |
| PFIZER INC. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Amgen Inc. | 2 | $33 |
| Novo Nordisk Inc | 1 | $26 |
Products named: CAMZYOS, VERQUVO, LEQVIO, LifeVest, Ambulatory Monitoring & Diagnostics Undivided, VYNDAQEL, Kerendia, REPATHA.
Industry payments across MS — which companies pay providers there.
